Page last updated: 2024-08-25

zoledronic acid and Focal Segmental Glomerulosclerosis

zoledronic acid has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Markowitz, GS; Perazella, MA	1
Amico, P; Bodmer, M; Haschke, M; Krähenbühl, S; Kummer, O; Mayr, M; Mihatsch, MJ	1

Reviews

1 review(s) available for zoledronic acid and Focal Segmental Glomerulosclerosis

Article	Year
Bisphosphonate nephrotoxicity. Kidney international, 2008, Volume: 74, Issue:11 Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kidney Diseases; Pamidronate; Practice Guidelines as Topic; Zoledronic Acid	2008

Other Studies

1 other study(ies) available for zoledronic acid and Focal Segmental Glomerulosclerosis

Article	Year
Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:8 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney; Male; Multiple Myeloma; Nephrotic Syndrome; Time Factors; Treatment Outcome; Zoledronic Acid	2007

Article

Year

Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:8

Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney; Male; Multiple Myeloma; Nephrotic Syndrome; Time Factors; Treatment Outcome; Zoledronic Acid

2007